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Objectives: Neurohumoral activation has been shown to be present in patients with chronic
obstructive pulmonary disease (COPD). The increase in respiratory muscle work might be
responsible for the observed elevation of sympathetic tone via a respiratory muscle ergoreflex
in these patients. The aim of this study is to investigate whether moderately increasing inspi-
ratory resistive loading will impact on sympathetic activity in healthy subjects and COPD
patients.
Methods: Efferent muscle sympathetic nerve activity, blood pressure, heart rate and respira-
tory movements were continuously measured in 15 patients and 15 healthy control subjects. In
order to increase work of breathing as evaluated by the tension-time index, inspiratory resis-
tive loading was performed while patients were breathing through a spirometer.
Results: At baseline, sympathetic nerve activity was significantly elevated in patients. Resis-
tive loading increased work of breathing (tension-time index) by roughly 110% (COPD) and
130% (controls) but did not significantly alter blood gases or sympathetic activity in either
group.
Conclusions: Doubling the work of breathing does not affect sympathetic activation in COPD
patients or healthy control subjects. Thus in COPD the respiratory muscle ergoreflex does
not seem to play a major role in sympathoexcitation.
ª 2009 Elsevier Ltd. All rights reserved.1 396 318; fax: þ49 551 396
goettingen.de (T. Raupach).
9 Elsevier Ltd. All rights reservedIntroduction
Chronic obstructive pulmonary disease (COPD) is a major
cause of death and disability worldwide. In COPD,
numerous extrapulmonary abnormalities are present..
108 T. Raupach et al.These include systemic inflammation, cachexia and skeletal
muscle dysfunction. COPD has thus been called a muscle1
and a systemic disease.2,3 Recent data demonstrate that
hypoxemic COPD causes marked neurohumoral activation.4
Notably, heightened sympathetic tone has also been noted
in patients suffering from congestive heart failure.5 Given
the similarities between pathophysiological findings in
heart failure and COPD6 and considering the negative
systemic consequences of neurohumoral activation, it is
conceivable that in the context of COPD, vegetative
dysfunction may well have direct implications for inflam-
mation, cachexia and skeletal muscle dysfunction.7
Currently, little is known about the cause of profound
sympathetic activation in patients with COPD. It has
recently been shown that reducing respiratory rate results
in an acute decrease in sympathetic activity in COPD
patients but not in healthy controls.8 However, work of
breathing was not assessed in that study.
Alterations in peripheral skeletal muscles and diaphragm
function are present and are related to exercise limitation
and severity of disease in patients with COPD.1,9,10 In COPD
the diaphragm is characterized by oxidative stress, sarco-
meric injury and ultimately by contractile protein
wasting.11,12 Similar to peripheral skeletal muscles, the
diaphragm contains unmylenated type III and IV sensory
nerve fibres.13,14 These muscle afferents constitute the
ergoreflex and activate the sympathetic nervous system at
rest14,15 and more noticeably during exercise.13,16 Indeed,
studies in healthy men using microneurographic recordings
revealed that high-intensity contractions of expiratory
muscles to the point of task failure cause a time-dependent
sympathoexcitation.17 In COPD patients, work of breathing
is increased even at rest.18
We therefore decided to evaluate whether moderate
inspiratory loading as present in COPD impacts on sympa-
thetic activation in COPD patients and in healthy controls.
To this end, sympathetic activity was measured using
microneurographic recordings of efferent muscle sympa-
thetic nerve activity (MSNA) in the peroneal nerve.19
Methods
Subjects
Non-smoking, normoxic individuals aged 30-80 years with
stable sinus rhythm and a diagnosis of COPD with
a FEV1 60% predicted who were on medical treatment
according to the Global Initiative for Chronic Obstructive
Lung Disease (GOLD) guideline20 were eligible for106
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Figure 1 Flow-pressure curves of the three reparticipation in the study. General exclusion criteria were
hypercapnia (PaCO2> 45 mmHg) based on arterial blood
gas analysis, recent (<3 months) history of COPD exacer-
bation, unstable heart disease, polyneuropathy, systemic
treatment with sympathomimetic drugs or diagnosis of
a disorder known to be accompanied by sympathetic
activation.
Healthy non-smoking volunteers were recruited from the
general public (advertisements) and matched by sex, age,
weight and smoking status to the patients. They did not
have any acute or chronic disease and were not on any
regular medication. Most patients and controls had also
participated in a previous investigation.8
Patients were asked not to take any diuretic drugs
before the measurements were completed. Informed
written consent was obtained from all patients and control
subjects.
Protocol
Experiments were conducted in the morning. Subjects were
in a supine position with a 30 elevation of the chest during
experiments. After obtaining a satisfactory nerve signal,
baseline measurements were performed for 20 min, after
which patients were asked to breathe through a mouth-
piece. Work of breathing was increased every four minutes
by inserting perforated plates to increase inspiratory
resistance. The patients breathed room air through
a mouthpiece connected to an occlusion valve. Three
different resistors were used (2.0, 4.5 and 10.0 hPa/l/s);
flow-pressure curves of these resistors were found to be
linear (see Fig. 1).
Simultaneous measurement of sympathetic activity and
blood gases would have caused an electrical interference
leading to decreased MSNA signal quality. Thus, in order to
determine SaO2 (Oxycount
, Andos MCC Karlsruhe,
Germany) and transcutaneous pCO2 (Tosca
, Linde Medical
Sensors, Basel, Switzerland) during inspiratory loading, the
protocol was repeated in six COPD patients and six healthy
controls belonging to the original study population. These
subjects showed no significant differences in baseline
parameters as compared to the other subjects.
In-vivo measurements
Sympathetic nerve activity was measured using micro-
neurographic recordings of efferent muscle sympathetic
nerve activity in the peroneal nerve of the right leg as
described previously.4,21 This method provides not only20
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sistors used to increase work of breathing.
Table 1 Baseline characteristics of study subjects.
COPD
(nZ 15)
Control
(nZ 15)
p Value
Age, years 60.9 1.4 60.7 1.4 0.919
Gender
[n male/female]
11/4 11/4 1
Smoking status
[% non-smokers]
100 100 1
Body mass index, kg/m2 27.0 1.1 26.5 0.9 0.735
Arterial pCO2 42.0 0.91 39.1 1.05 0.048
Arterial pO2 76.5 2.3 82.5 2.8 0.112
FEV1, % predicted 46.4 3.7 101.4 2.5 <0.001
FEV1/vital capacity 53.5 2.8 79.0 1.0 <0.001
Vital capacity, %
predicted
63.1 4.1 95.2 3.0 <0.001
RV/TLC 47.3 3.2 35.1 2.9 0.017
p0.1, kPa 0.39 0.05 0.11 0.03 <0.001
pimax, kPa 5.64 0.64 8.41 0.95 0.026
Systolic blood pressure,
mmHg
129.8 5.9 145.7 6.1 0.085
Diastolic blood pressure,
mmHg
67.8 3.3 74.8 3.0 0.285
Heart rate, min1 78.3 3.1 70.8 2.0 0.098
Respiratory rate, min1 15.1 0.9 15.2 1.1 0.72
FEV1, forced exspiratory volume in 1 second; RV, residual
volume; TLC, total lung capacity; p0.1, mouth occlusion pres-
sure at 0.1 seconds; pimax, maximal inspiratory pressure.
Inspiratory loading in COPD 109greater reproducibility than other measures of sympathetic
activity, but also a clearer and more consistent reflection of
acute and chronic changes in sympathetic activity.19,22 Blood
pressure was measured continuously and noninvasively with
the Portapres device (FMS, Amsterdam, Netherlands).
Heart rate was derived from a continuous electrocardio-
graphic (ECG) recording. During experiments, tidal volume,
breathing rate andmouth occlusion pressure weremeasured
using an ambulatory spirometry device (Jaeger Flowscreen,
VIASYS Healthcare, Hoechberg, Germany).
Work of breathing can be estimated non-invasively using
mouth occlusion pressure and the tension-time index.23,24
The latter, given by p0.1/pimax TI/Ttot (where p0.1 is
mouth occlusion pressure, pimax is maximal inspiratory
pressure, and TI/Ttot is duty cycle), is closely related to the
results of more invasive measurements, thus reflecting
work of breathing.18,24e27
Data analysis
Data recording and analysis was performed using the
Modular Intensive Care Data Acquisition System (MIDAS)
developed by P.H. in cooperation with the Mannheim
Biomedical Engineering Laboratories (X.P. Ngyen, MABEL,
Institut fu¨r Biomedizinische Technik, Hochschule Man-
nheim, Germany).8 Sympathetic bursts were quantified
manually and independently by two observers (T.R. and
F.B.) blinded as to subject and intervention. In our insti-
tution, the intraobserver variation in identifying bursts is
5%, and the interobserver variation is 11%.4 MSNA was
computed as bursts/min and bursts/100 heartbeats, both of
which yielded similar results. Thus, data are only presented
as bursts/100 heart beats. Statistical analyses were carried
out with SPSS 12.0.1 (SPSS Inc., Chicago, Illinois, USA). All
data in the text and tables are presented as mean -
 standard error of the mean (SEM). Statistical significance
was accepted at a value of p 0.05. Repeated-measures
analysis of variance (ANOVA) with time as within-groups
factor and the time by treatment interaction as indicator of
differential changes in both study groups was used to
analyze the effects of resistive loading.
The Institutional Review Board of Goettingen University
approved of the study protocol.
Results
Baseline characteristics
A total of 15 patients and 15 control subjects matched for
age, weight and height were included in the study. All
patients used long-acting inhaled b2 agonists, eight patients
added inhaled tiotropium, and seven used inhaled gluco-
corticosteroids. Non-invasive ventilation was not used by
any patient. Medications used for conditions other than
COPD included aspirin (nZ 2), statins (nZ 4), L-thyroxin
(nZ 1) and ACE inhibitors (nZ 2). Control subjects did not
use any medication. The baseline characteristics of all
participants are summarized in Table 1. Under resting
conditions, MSNA was significantly higher in patients than in
control subjects (55.3 4.7 bursts/100 heartbeats vs.
39.9 2.7 bursts/100 heartbeats, pZ 0.013).Spirometry, respiratory muscle function and blood
gases during resistive loading
The increase in work of breathing caused by inserting
perforated plates into the inspiratory leg of the spirometer
led to an increase in p0.1 in both COPD patients and control
subjects. All subjects reported to have experienced an
increased effort with increasing resistors. Compared with
baseline values, adding the strongest resistor (10 hPa/l/s)
caused p0.1 to amount to 10.6 4.6% of pimax in COPD
patients and 7.7 4.2% of pimax in healthy controls. Using
this resistor increased the tension-time index by
108.9 25.2% in COPD patients and 128.7 21.1% in
healthy controls (pZ 0.566) while tidal volume and respi-
ratory rate remained unchanged in both groups (p for
interaction n.s.; Fig. 2, Table 2). However, there was an
increase in minute ventilation (Table 2). Analysis of trans-
cutaneous blood gas measurements revealed no significant
change in oxygen saturation or pCO2 upon resistive loading
(p for interaction n.s.; Table 3).
Effects of resistive loading on haemodynamics and
sympathetic activity
As is shown in Table 2, increased work of breathing caused
an increase in heart rate and systolic blood pressure in both
groups. The effects of resistive loading on sympathetic
activity are displayed in Fig. 3. Throughout the complete
study protocol, MSNA was significantly higher in COPD
patients than in healthy controls. Repeated-measures
0.05 p = 0.010 p = 0.957 p = 0.011
0.04
0.03
0.02
T
i
m
e
-
T
e
n
s
i
o
n
-
I
n
d
e
x
0
,
1
[
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
]
0.01
p = 0.002 p = 0.090 p = 0.001
0 2 4.5 10Inspiratory resistance[hPa/l/s]
Figure 2 Effect of resistive loading on tension-time index.
Black columns, COPD patients (nZ 15); grey columns, control
subjects (nZ 15); ANOVA: p for time< 0.001; p for
groupZ 0.157; p for interactionZ 0.354.
110 T. Raupach et al.analysis of variance (ANOVA) yielded a significant effect for
time by treatment analysis; however there was no signifi-
cant change in MSNA over time in either group.
Discussion
We evaluate here, for the first time, the effect of inspira-
tory loading on sympathetic activity in patients suffering
from COPD: Doubling the work of breathing had no
apparent effect on muscle sympathetic activity. Thus, it
seems unlikely that increased work of breathing plays
a major role in the striking sympathoexcitation present in
COPD patients.
Muscle atrophy, structural and biochemical alterations,
as well as endothelial dysfunction with reduced muscle
perfusion account for skeletal muscle dysfunction in
COPD.28 Unlike skeletal muscle, the diaphragm is
constantly active. Diaphragm function is impaired in COPD
patients, which is of clinical relevance because it contrib-
utes to exercise intolerance.10,11 Reduced diaphragm
function cannot simply be ascribed to emphysema-related
diaphragm shortening.10 Whereas the shift in fibre typeTable 2 Effects of resistive loading on ventilation and haemod
Inspiratory resistance [hPa/l/s] 0 2
Tidal volume [l] COPD 0.66 0.07 0.67 0.06
Control 0.87 0.10 0.84 0.09
Respiratory rate [min1] COPD 15.1 0.9 15.1 0.7
Control 15.4 1.2 16.4 1.4
Minute ventilation [l/min] COPD 9.4 0.7 9.6 0.6
Control 12.4 1.2 12.7 1.3
Inspiratory time/breath
duration [%]
COPD 40.5 1.6 41.0 1.0
Control 46.8 1.1 47.6 1.2
Heart rate [min1] COPD 78.3 3.1 79.2 3.2
Control 70.8 2.0 70.9 1.9
Systolic blood
pressure [mmHg]
COPD 129.8 5.9 131.5 6.9
Control 145.7 6.1 146.4 5.4
Diastolic blood
pressure [mmHg]
COPD 67.8 3.3 67.4 3.3
Control 74.8 3.0 73.3 2.9towards oxidative type I fibres in COPD diaphragm is
regarded as beneficial, rendering the overloaded dia-
phragm more resistant to fatigue, it became clear that
oxidative stress and sarcomeric injury are present and
ultimately lead to contractile protein wasting.11,12 The
diaphragm contains unmylenated type III and IV sensory
nerve fibres13,14 contributing to the ergoreflex which acti-
vates the sympathetic nervous system especially during
exercise.13e16
In healthy humans, diaphragm-fatiguing resistive loading
impacts on blood flow in limb muscles, probably via
increased sympathetic outflow.29 Correspondingly, studies
in healthy men using microneurographic recordings
revealed that high-intensity contractions of respiratory
muscles to the point of task failure cause a time-dependent
sympathoexcitation.17 Dyspnoea, muscle dysfunction and
fatigue are not only present in subjects suffering from
COPD but also in patients with heart failure.6 The latter
were found to exhibit heightened basal sensitivity of
muscle mechanoreceptors to metabolic and mechanical
stimuli resulting in an exaggerated increase in MSNA during
exercise or acute venous congestion.5,30e33
In aggregate there is evidence from animals, healthy
men and patients with heart failure that strenuous respi-
ration causes sympathetic activation. Our data on the
effect of a moderate increase in the work of breathing in
patients with COPD and healthy controls revealed no
significance (p ANOVA for time) for the effect of the resis-
tors on MSNA. There was a borderline significance for
interaction in the ANOVA that was due to the actual
decrease in MSNA with the highest resistor in the patients
but not the controls (Fig. 3). This finding cannot be viewed
as an apparent relation between the increase in work of
breathing and MSNA in either group. Thus, moderate
loading of respiratory muscles as present in patients with
COPD does not cause relevant sympathetic activation. It is
therefore unlikely that the striking sympathetic activation
present in COPD patients is due to respiratory muscle
dysfunction at rest.ynamics.
4.5 10 p Group p Time p ANOVA
0.68 0.05 0.70 0.05 0.079 0.352 0.920
0.88 0.11 0.93 0.11
15.3 0.6 14.6 0.7 0.262 0.229 0.188
17.0 1.1 16.7 1.1
10.1 0.5 10.0 0.5 0.009 0.004 0.187
14.0 1.3 14.6 1.4
42.6 1.3 44.7 1.6 <0.001 <0.001 0.952
48.5 0.8 50.8 1.2
79.4 3.2 81.0 3.3 0.062 0.006 0.265
73.1 1.5 72.9 1.3
134.1 5.9 140.2 6.3 0.163 0.002 0.106
146.2 5.9 147.6 5.1
68.1 3.3 70.5 3.4 0.156 0.063 0.730
74.8 2.5 75.5 2.5
Table 3 Effects of resistive loading on blood gases in COPD patients (nZ 6) and healthy controls (nZ 6).
Inspiratory resistance [hPa/l/s] 0 2 4.5 10 p Group p Time p ANOVA
Oxygen saturation [%] COPD 91.5 1.8 91.2 1.8 91.4 2.3 91.2 2.1 0.057 0.263 0.801
Control 96.5 0.8 96.5 0.2 96.5 0.2 97.0 0.5
Transcutaneous pCO2 [mmHg] COPD 43.8 1.3 44.7 1.6 45.0 2.0 45.0 1.8 0.014 0.362 0.621
Control 36.5 2.1 36.8 3.0 37.8 3.1 37.3 3.0
Inspiratory loading in COPD 111It is known that respiratory rate and tidal volume affect
MSNA.8,34 In the present study, resistive loading of respi-
ratory muscles did not alter tidal volume or respiratory
rate. The absence of an effect of resistive loading on MSNA
thus cannot be ascribed to changes in these parameters
that would counteract the true effect of diaphragmatic
strain on sympathetic tone.35 Furthermore, our findings
regarding oxygen saturation and transcutaneous pCO2 are in
keeping with the assumption that, unlike prolonged and
large resistive loading eventually leading to task
failure,36,37 short and moderate resistive loading is unlikely
to alter blood gas homeostasis.38 However, there was an
increase in minute ventilation that can be ascribed to the
increased work of breathing. It is unlikely that these
changes impact on the autonomic nervous system.13,14
The increase in systolic blood pressure observed in both
COPD patients and healthy controls during resistive loading
might have caused a slight inhibition (or counteracted
a strain-induced increase) of sympathetic tone via the
activation of arterial baroreceptors.35 Although we cannot
disentangle the underlying mechanism in our study, we can
state that resistive loading has no major effect on sympa-
thetic activity.
Long-term use of NIV has proven beneficial regarding
dyspnoea severity and health-related quality of life in
patients with stable hypercapnic COPD.39 Interestingly,
a recent study suggested that NIV might yield a favourable
impact on the autonomous nervous system as assessed by
heart rate variability.40 Although, in the present study,
moderate inspiratory loading did not affect sympathetic
outflow, long-lasting beneficial effects of sustained muscle
unloading on MSNA cannot be excluded. This hypothesis,
which may help to understand the therapeutic effects of
NIV, needs to be tested in future studies.70
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Figure 3 Effect of resistive loading on MSNA. Black, COPD
patients (nZ 15); grey, control subjects (nZ 15); ANOVA: p for
timeZ 0.267, p for groupZ 0.010; p for interactionZ 0.047.Study limitations
Since only short-term changes in work of breathing were
studied here, no conclusions on the effects of long-term
inspiratory loading on sympathovagal balance can be drawn
from our study. Inspiratory loading applied over several days
to weeks seems both physically and psychologically arduous.
As discussed above, the respiratory muscle metaboreflex
is operative mainly during strenuous respiration.41 We used
only moderate inspiratory resistors in our COPD patients.
This approach was adopted so as to maximize patient safety
since injury of the diaphragm has been observed in several
animal models of inspiratory loading.42,43 Indeed, sarcomere
disruption with acute inspiratory loading was much more
common in patients with COPD than in healthy subjects.12
Nevertheless, even the moderate inspiratory resistors
caused the loaded controls to experience higher work of
breathing as compared to the unloaded COPD patients and
about double the work of breathing in both groupsewithout
a significant impact on MSNA in either group.
Work of breathing was assessed non-invasively in the
present study since simultaneous measurement of MSNA
and transdiaphragmatic pressure would have been too
demanding for our patients. Moreover, since the main goal
of this measurement was not to exactly determine work of
breathing but to quantify changes elicited by inserting
resistors into the inspiratory leg of the spirometer system,
use of a non-invasive method seemed appropriate. The
tension-time index has been shown to reliably capture
changes in work of breathing in patients with COPD at
rest24,27 and during exercise18 although a slight underesti-
mation of the true work of breathing cannot be excluded
when using this method. However, the tension-time index
has proved useful to evaluate the work of breathing in
patients with neuromuscular diseases.25,26 Lastly, dynamic
hyperinflation might have occurred during inspiratory
loading and would not have been detected in our protocol.
This is of interest since dynamic hyperinflation can impact
on the work of breathing.44Conclusions
In summary, patients with COPD show sympathetic excita-
tion as compared to healthy control subjects. An increase in
work of breathing of about 100% does not elicit any further
sympathetic activation, rendering respiratory muscle
dysfunction an unlikely cause of autonomic dysfunction in
COPD. Future investigations will have to address direct
effects of unloading the respiratory muscle by NIV on
sympathovagal balance in COPD.
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